$6.8 Billion is the total value of Orbimed Advisors's 120 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 51.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $374,944,000 | +24.8% | 4,992,600 | +4.5% | 5.51% | +2.8% |
| BIIB | Buy | BIOGEN IDEC INC | $306,159,000 | +23.9% | 1,095,100 | +6.7% | 4.50% | +2.0% |
| CELG | Buy | CELGENE CORP | $296,894,000 | +47.4% | 1,757,100 | +34.4% | 4.36% | +21.4% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $290,465,000 | +20.6% | 5,465,000 | +5.0% | 4.27% | -0.7% |
| AMGN | Sell | AMGEN INC | $286,945,000 | -2.5% | 2,515,300 | -4.3% | 4.22% | -19.7% |
| RLYP | New | RELYPSA INC | $248,539,000 | – | 9,941,549 | +100.0% | 3.65% | – |
| INCY | Sell | INCYTE CORP | $206,013,000 | +20.7% | 4,069,000 | -9.0% | 3.03% | -0.6% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $203,347,000 | +26.7% | 738,800 | +44.0% | 2.99% | +4.3% |
| MDVN | Buy | MEDIVATION INC | $199,342,000 | +45.6% | 3,123,500 | +36.7% | 2.93% | +19.9% |
| ABBV | Buy | ABBVIE INC | $198,613,000 | +154.9% | 3,760,900 | +115.9% | 2.92% | +110.0% |
| MYL | Sell | MYLAN INC | $182,909,000 | -5.1% | 4,214,500 | -16.5% | 2.69% | -21.8% |
| HCA | Buy | HCA HOLDINGS INC | $179,294,000 | +37.4% | 3,758,000 | +23.1% | 2.64% | +13.1% |
| ILMN | Buy | ILLUMINA INC | $176,590,000 | +37.1% | 1,596,800 | +0.2% | 2.60% | +12.9% |
| A | Buy | AGILENT TECHNOLOGIES INC | $172,577,000 | +49.9% | 3,017,600 | +34.4% | 2.54% | +23.5% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $170,833,000 | +19.9% | 1,534,200 | -0.8% | 2.51% | -1.2% |
| MRK | Sell | MERCK & CO INC NEW | $127,477,000 | -55.9% | 2,547,000 | -58.1% | 1.87% | -63.7% |
| B108PS | New | ACTAVIS PLC | $119,784,000 | – | 713,000 | +100.0% | 1.76% | – |
| PRGO | New | PERRIGO CO | $118,625,000 | – | 773,000 | +100.0% | 1.74% | – |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $118,461,000 | -20.2% | 1,734,934 | -19.4% | 1.74% | -34.3% |
| ITMN | Buy | INTERMUNE INC | $113,377,000 | +155.3% | 7,697,000 | +166.6% | 1.67% | +110.1% |
| PFE | Sell | PFIZER INC | $108,828,000 | -5.5% | 3,553,000 | -11.4% | 1.60% | -22.2% |
| PODD | Buy | INSULET CORP | $107,163,000 | +3.7% | 2,888,500 | +1.3% | 1.58% | -14.6% |
| IPXL | Buy | IMPAX LABORATORIES INC | $106,533,000 | +58.4% | 4,237,600 | +29.0% | 1.57% | +30.5% |
| SHPG | Buy | SHIRE PLCsponsored adr | $102,294,000 | +23.5% | 724,000 | +4.8% | 1.50% | +1.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $99,482,000 | -12.9% | 1,414,100 | -10.6% | 1.46% | -28.2% |
| ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $90,399,000 | -18.0% | 1,287,000 | -27.8% | 1.33% | -32.4% |
| CFN | Buy | CAREFUSION CORP | $86,469,000 | +94.7% | 2,171,500 | +80.5% | 1.27% | +60.5% |
| AGN | Buy | ALLERGAN INC | $86,109,000 | +220.5% | 775,200 | +161.0% | 1.26% | +164.1% |
| XLRN | New | ACCELERON PHARMA INC | $83,859,000 | – | 2,117,648 | +100.0% | 1.23% | – |
| AET | Sell | AETNA INC NEW | $80,463,000 | -19.1% | 1,173,100 | -24.5% | 1.18% | -33.3% |
| ZBH | Buy | ZIMMER HLDGS INC | $77,832,000 | +2005.8% | 835,200 | +1756.0% | 1.14% | +1633.3% |
| MOH | Buy | MOLINA HEALTHCARE INC | $71,693,000 | +9.8% | 2,063,100 | +12.5% | 1.05% | -9.5% |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $66,209,000 | -17.3% | 4,794,300 | +4.4% | 0.97% | -31.9% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $59,562,000 | -37.4% | 791,000 | -40.5% | 0.88% | -48.5% |
| EXAS | Buy | EXACT SCIENCES CORP | $58,624,000 | +6.1% | 4,989,300 | +6.6% | 0.86% | -12.6% |
| AFFX | Buy | AFFYMETRIX INC | $58,362,000 | +41.7% | 6,810,000 | +2.4% | 0.86% | +16.7% |
| EXEL | Buy | EXELIXIS INC | $57,555,000 | +13.1% | 9,389,000 | +7.4% | 0.85% | -6.8% |
| JNJ | Sell | JOHNSON & JOHNSON | $57,335,000 | +1.3% | 626,000 | -4.1% | 0.84% | -16.5% |
| MCK | Buy | MCKESSON CORP | $57,297,000 | +487.6% | 355,000 | +367.1% | 0.84% | +383.9% |
| FLDM | Buy | FLUIDIGM CORP DEL | $55,356,000 | +78.1% | 1,446,008 | +2.1% | 0.81% | +46.7% |
| SYK | Buy | STRYKER CORP | $53,853,000 | +1107.2% | 716,700 | +985.9% | 0.79% | +888.8% |
| STJ | Buy | ST JUDE MED INC | $51,642,000 | +702.3% | 833,600 | +594.7% | 0.76% | +560.0% |
| HNT | Buy | HEALTH NET INC | $46,327,000 | +15.1% | 1,561,400 | +23.0% | 0.68% | -5.2% |
| QGEN | New | QIAGEN NV | $45,882,000 | – | 1,927,000 | +100.0% | 0.67% | – |
| V107SC | Sell | WELLPOINT INC | $39,635,000 | -60.7% | 429,000 | -64.4% | 0.58% | -67.6% |
| PRTA | New | PROTHENA CORP PLC | $31,877,000 | – | 1,202,000 | +100.0% | 0.47% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $31,730,000 | – | 1,310,600 | +100.0% | 0.47% | – |
| OSUR | Buy | ORASURE TECHNOLOGIES INC | $31,375,000 | +7.4% | 4,988,000 | +2.6% | 0.46% | -11.5% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $30,949,000 | +23.4% | 232,900 | +7.9% | 0.46% | +1.6% |
| BMY | Buy | BRISTOL MYERS SQUIBB COcall | $29,233,000 | +152.7% | 550,000 | +120.0% | 0.43% | +108.7% |
| ISRG | New | INTUITIVE SURGICAL INC | $28,614,000 | – | 74,500 | +100.0% | 0.42% | – |
| INCYTE CORPnote 4.750%10/0 | $28,454,000 | +30.6% | 4,992,000 | 0.0% | 0.42% | +7.5% | ||
| PRGO | Buy | PERRIGO COcall | $26,856,000 | +227.8% | 175,000 | +163.6% | 0.40% | +170.5% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $26,792,000 | -34.6% | 2,679,216 | -14.0% | 0.39% | -46.1% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $26,678,000 | -11.2% | 5,325,000 | +10.2% | 0.39% | -26.9% |
| XNPT | Buy | XENOPORT INC | $26,397,000 | +10.1% | 4,590,800 | +8.7% | 0.39% | -9.3% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $24,661,000 | +181.9% | 957,700 | +192.9% | 0.36% | +132.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $24,574,000 | +277.5% | 2,631,000 | +357.6% | 0.36% | +211.2% |
| ARWR | New | ARROWHEAD RESH CORP | $23,099,000 | – | 2,128,900 | +100.0% | 0.34% | – |
| DRTX | DURATA THERAPEUTICS INC | $22,839,000 | +41.5% | 1,785,714 | 0.0% | 0.34% | +16.7% | |
| CERS | Buy | CERUS CORP | $21,769,000 | +26.6% | 3,375,000 | +31.9% | 0.32% | +4.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $21,192,000 | +21.7% | 1,274,332 | +10.9% | 0.31% | 0.0% |
| ATRS | Buy | ANTARES PHARMA INC | $20,531,000 | +15.9% | 4,592,000 | +5.2% | 0.30% | -4.4% |
| XOMA | Buy | XOMA CORP DEL | $19,043,000 | +52.2% | 2,829,627 | +1.5% | 0.28% | +25.6% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $18,947,000 | -26.1% | 255,000 | -24.6% | 0.28% | -39.2% |
| MDT | Sell | MEDTRONIC INC | $18,537,000 | -15.1% | 323,000 | -21.2% | 0.27% | -30.3% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $18,432,000 | +28.0% | 157,000 | +13.8% | 0.27% | +5.4% |
| BAX | Buy | BAXTER INTL INC | $16,970,000 | +58.7% | 244,000 | +49.9% | 0.25% | +30.4% |
| MEIP | New | MEI PHARMA INC | $15,936,000 | – | 1,989,500 | +100.0% | 0.23% | – |
| CAH | Buy | CARDINAL HEALTH INC | $15,386,000 | +55.9% | 230,300 | +21.7% | 0.23% | +28.4% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $14,554,000 | +119.8% | 115,000 | +59.7% | 0.21% | +81.4% |
| AMBI | AMBIT BIOSCIENCES CORP | $14,371,000 | -37.8% | 1,490,769 | 0.0% | 0.21% | -48.8% | |
| MGNX | New | MACROGENICS INC | $13,493,000 | – | 491,897 | +100.0% | 0.20% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $13,301,000 | – | 320,200 | +100.0% | 0.20% | – |
| ABBV | ABBVIE INCcall | $13,203,000 | +18.1% | 250,000 | 0.0% | 0.19% | -3.0% | |
| VNDA | New | VANDA PHARMACEUTICALS INC | $12,286,000 | – | 990,000 | +100.0% | 0.18% | – |
| ARQL | Buy | ARQULE INC | $12,259,000 | +20.5% | 5,702,000 | +30.6% | 0.18% | -1.1% |
| ABT | Sell | ABBOTT LABS | $11,691,000 | -11.9% | 305,000 | -23.8% | 0.17% | -27.4% |
| ILMN | New | ILLUMINA INCcall | $11,059,000 | – | 100,000 | +100.0% | 0.16% | – |
| MRGE | Buy | MERGE HEALTHCARE INC | $10,738,000 | -4.2% | 4,628,500 | +7.7% | 0.16% | -21.0% |
| SVA | Sell | SINOVAC BIOTECH LTD | $10,022,000 | -11.1% | 1,637,500 | -13.1% | 0.15% | -26.9% |
| ZTS | New | ZOETIS INCcl a | $9,121,000 | – | 279,000 | +100.0% | 0.13% | – |
| DVA | Buy | DAVITA HEALTHCARE PARTNERS I | $9,062,000 | +22.5% | 143,000 | +10.0% | 0.13% | +0.8% |
| FRX | New | FOREST LABS INCcall | $9,005,000 | – | 150,000 | +100.0% | 0.13% | – |
| GEVA | SYNAGEVA BIOPHARMA CORP | $8,414,000 | +2.1% | 130,000 | 0.0% | 0.12% | -15.6% | |
| FRX | Buy | FOREST LABS INC | $8,344,000 | +62.5% | 139,000 | +15.8% | 0.12% | +33.7% |
| NSPR | INSPIREMD INC | $8,352,000 | +5.6% | 3,395,000 | 0.0% | 0.12% | -12.8% | |
| New | OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $7,317,000 | – | 7,500,000 | +100.0% | 0.11% | – | |
| VCRA | VOCERA COMMUNICATIONS INC | $6,985,000 | -16.1% | 447,500 | 0.0% | 0.10% | -30.9% | |
| XNCR | New | XENCOR INC | $6,422,000 | – | 702,600 | +100.0% | 0.09% | – |
| CBST | Sell | CUBIST PHARMACEUTICALS INC | $6,198,000 | -89.2% | 90,000 | -90.0% | 0.09% | -91.1% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $6,219,000 | – | 55,000 | +100.0% | 0.09% | – |
| MDXG | New | MIMEDX GROUP INC | $6,118,000 | – | 700,000 | +100.0% | 0.09% | – |
| PTX | PERNIX THERAPEUTICS HLDGS IN | $5,848,000 | -7.4% | 2,320,800 | 0.0% | 0.09% | -23.9% | |
| CRIS | CURIS INC | $5,499,000 | -36.8% | 1,950,100 | 0.0% | 0.08% | -47.7% | |
| CVD | Buy | COVANCE INC | $5,196,000 | +25.2% | 59,000 | +22.9% | 0.08% | +2.7% |
| TECH | Sell | TECHNE CORP | $4,734,000 | -77.8% | 50,000 | -81.2% | 0.07% | -81.6% |
| QCOR | New | QUESTCOR PHARMACEUTICALS INCcall | $4,628,000 | – | 85,000 | +100.0% | 0.07% | – |
| FATE | New | FATE THERAPEUTICS INC | $4,409,000 | – | 702,000 | +100.0% | 0.06% | – |
| QCOR | QUESTCOR PHARMACEUTICALS INC | $4,356,000 | -6.1% | 80,000 | 0.0% | 0.06% | -22.9% | |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $4,373,000 | -6.7% | 580,000 | -9.3% | 0.06% | -23.8% |
| UPI | UROPLASTY INC | $3,941,000 | -17.5% | 1,443,500 | 0.0% | 0.06% | -31.8% | |
| CPRX | CATALYST PHARM PARTNERS INC | $3,695,000 | -36.1% | 1,895,000 | 0.0% | 0.05% | -47.6% | |
| HSP | New | HOSPIRA INC | $3,509,000 | – | 85,000 | +100.0% | 0.05% | – |
| INCY | New | INCYTE CORPcall | $3,544,000 | – | 70,000 | +100.0% | 0.05% | – |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $3,374,000 | -60.6% | 135,000 | -56.7% | 0.05% | -67.3% |
| BLRX | Sell | BIOLINERX LTDsponsored adr | $3,189,000 | +9.1% | 1,135,000 | -15.0% | 0.05% | -9.6% |
| ANTH | ANTHERA PHARMACEUTICALS INC | $2,864,000 | -23.6% | 932,750 | 0.0% | 0.04% | -37.3% | |
| QLTI | Sell | QLT INC | $2,507,000 | -9.8% | 450,000 | -25.0% | 0.04% | -26.0% |
| BONE | Buy | BACTERIN INTL HLDGS INC | $1,627,000 | +38.5% | 3,254,386 | +85.5% | 0.02% | +14.3% |
| BIOD | Sell | BIODEL INC | $1,248,000 | -55.9% | 547,443 | -39.0% | 0.02% | -64.0% |
| AMRN | AMARIN CORP PLCspons adr new | $1,182,000 | -68.8% | 600,000 | 0.0% | 0.02% | -75.0% | |
| OPHT | New | OPHTHOTECH CORP | $1,116,000 | – | 34,500 | +100.0% | 0.02% | – |
| New | ENDOLOGIX INCnote 2.250%12/1 | $1,016,000 | – | 1,000,000 | +100.0% | 0.02% | – | |
| EXAS | New | EXACT SCIENCES CORPput | $1,013,000 | – | 86,200 | +100.0% | 0.02% | – |
| CHDX | Buy | CHINDEX INTERNATIONAL INC | $627,000 | +15.0% | 36,000 | +12.5% | 0.01% | -10.0% |
| New | BIOMARIN PHARMACEUTICAL INCnote 1.500%10/1 | $538,000 | – | 500,000 | +100.0% | 0.01% | – | |
| New | BIOMARIN PHARMACEUTICAL INCnote 0.750%10/1 | $537,000 | – | 500,000 | +100.0% | 0.01% | – | |
| SPY | Buy | SPDR S&P 500 ETF TRput | $370,000 | -98.9% | 250,000 | +25.0% | 0.01% | -99.2% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDput | $152,000 | -98.7% | 200,000 | -33.3% | 0.00% | -99.0% |
| MYGN | Exit | MYRIAD GENETICS INCput | $0 | – | -30,000 | -100.0% | -0.01% | – |
| WX | Exit | WUXI PHARMATECH CAYMAN INC | $0 | – | -31,500 | -100.0% | -0.02% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -60,800 | -100.0% | -0.02% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INCput | $0 | – | -139,400 | -100.0% | -0.03% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -170,000 | -100.0% | -0.04% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INCcall | $0 | – | -250,000 | -100.0% | -0.04% | – |
| DNDNQ | Exit | DENDREON CORP | $0 | – | -868,000 | -100.0% | -0.04% | – |
| Exit | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $0 | – | -2,315,000 | -100.0% | -0.05% | – | |
| INFI | Exit | INFINITY PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.05% | – |
| CELGZ | Exit | CELGENE CORPright 12/31/2030 | $0 | – | -360,900 | -100.0% | -0.05% | – |
| MDVN | Exit | MEDIVATION INCput | $0 | – | -50,000 | -100.0% | -0.05% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -50,000 | -100.0% | -0.06% | – |
| VPHM | Exit | VIROPHARMA INCput | $0 | – | -100,000 | -100.0% | -0.07% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -0.08% | – |
| BCR | Exit | BARD C R INC | $0 | – | -38,000 | -100.0% | -0.08% | – |
| ENDP | Exit | ENDO HEALTH SOLUTIONS INC | $0 | – | -105,000 | -100.0% | -0.08% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -222,500 | -100.0% | -0.11% | – |
| MOH | Exit | MOLINA HEALTHCARE INCcall | $0 | – | -215,300 | -100.0% | -0.14% | – |
| HNT | Exit | HEALTH NET INCcall | $0 | – | -250,000 | -100.0% | -0.14% | – |
| AVNR | Exit | AVANIR PHARMACEUTICALS INCcl a new | $0 | – | -1,863,400 | -100.0% | -0.14% | – |
| VPHM | Exit | VIROPHARMA INCcall | $0 | – | -250,000 | -100.0% | -0.18% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -8,986,000 | -100.0% | -0.19% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -272,000 | -100.0% | -0.20% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.21% | – |
| ONXX | Exit | ONYX PHARMACEUTICALS INCput | $0 | – | -112,300 | -100.0% | -0.25% | – |
| A | Exit | AGILENT TECHNOLOGIES INCcall | $0 | – | -300,000 | -100.0% | -0.27% | – |
| RCPT | Exit | RECEPTOS INC | $0 | – | -644,450 | -100.0% | -0.30% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -272,000 | -100.0% | -0.34% | – |
| Q | Exit | QUINTILES TRANSNATIO HLDGS I | $0 | – | -440,000 | -100.0% | -0.35% | – |
| ACT | Exit | ACTAVIS INCcall | $0 | – | -150,000 | -100.0% | -0.38% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -418,300 | -100.0% | -0.48% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -438,000 | -100.0% | -0.60% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -766,000 | -100.0% | -0.66% | – |
| SPY | Exit | SPDR S&P 500 ETF TRtr unit | $0 | – | -300,000 | -100.0% | -0.90% | – |
| WCRX | Exit | WARNER CHILCOTT PLC IRELAND | $0 | – | -2,449,100 | -100.0% | -1.00% | – |
| ACT | Exit | ACTAVIS INC | $0 | – | -475,100 | -100.0% | -1.22% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.